DoW Melanoma Research Program Focused Program Award - Rare Melanomas
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 5, 2026
- Amount
- Program total $5.6M
- Closes
- Oct 14, 2026 (in 31 days)
Similar opportunities open now
- DoW Melanoma Research Program Idea AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 31 days
- DoW Melanoma Research Program Melanoma Academy Scholar AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 31 days
- DoW Melanoma Research Program Team Science AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 31 days
- DoW Melanoma Research Program Survivorship Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 31 days
- DoW Pancreatic Cancer Research Program, Focused Pilot AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 24 days
Classification and identifiers
- Solicitation number
- HT942526MRPFPARM
- Assistance listing (CFDA)
- 12.420
Amount
Program total $5.6M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Focused Program Award – Rare Melanomas, supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas. Distinctive Features: · *Updated for FY26* Investigators must include at least one rare melanoma survivor or patient advocate as part of the project team who will provide advice and consultation throughout planning, implementation, and results dissemination to maximize research impact. · This is a partnering mechanism, requiring an Initiating Principal Investigator (PI) and at least one, but not more than two, Partnering PIs, see Figure 1 . Each named PI is expected to be a Project Leader f...